Silence Therapeutics plc (OTCMKTS:SLNCF – Get Free Report) was up 3.2% during trading on Thursday . The company traded as high as $5.78 and last traded at $5.78. Approximately 100 shares changed hands during trading, a decline of 94% from the average daily volume of 1,541 shares. The stock had previously closed at $5.60.
Silence Therapeutics Price Performance
The company’s 50-day moving average is $6.14 and its 200-day moving average is $6.75.
About Silence Therapeutics
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company's mRNAi GalNAc Oligonucleotide Discovery platform consists of precision engineered product candidates designed to target specific disease-associated genes in the liver.
Recommended Stories
- Five stocks we like better than Silence Therapeutics
- Earnings Per Share Calculator: How to Calculate EPS
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- Where Do I Find 52-Week Highs and Lows?
- MarketBeat Week in Review – 11/4 – 11/8
- How to Calculate Inflation Rate
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for Silence Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silence Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
